« Return to News | Study Conduct | Drug Sponsors

China: a quick and cost-efficient direction for drug development

Monday, April 25, 2011 12:12 PM

U.S. companies seeking to conduct clinical trials of new drugs and medical devices, Dr. R. Stephen Porter of Tennessee says China provides a lower-cost setting in which jobs can be accomplished more quickly, according to The Tennessean.

Porter’s consulting company, Dragon Bio-Consultants, helps U.S. drug companies license their products in China; he also helps Chinese companies license their products in the U.S. by assisting with FDA processes.

Porter partners with Chinese companies that can take new drugs through development, including testings. As one example of time efficiency, he cites a U.S. company that approved five drug compounds for human study in two years in China, in contrast to that of the U.S. pharma industry where one compound takes eight years to develop. 

The U.S. company paid $4 million in contract fees for the work done in China while pharmaceutical processes, on average, can cost $25 million to be done in the U.S.

“That’s leveraging time and costs,” he said. “That’s what China is all about— half the money, twice the productivity and 10 times the value. That’s why I’m in China. They have more than two trillion of our dollars they want to invest in pharmaceuticals and health care, and they want to access both the Chinese and the Western market.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.